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Background: Pdx1 interacts with the methyltransferase Set7/9 to transactivate  cell genes.
Results:Methylation of Pdx1 residue Lys-131 by Set7/9 augments Pdx1 activity.
Conclusion: The ability of Pdx1 to regulate genes in  cells is partially dependent upon its methylation by Set7/9.
Significance: This study reveals a previously unappreciated role for Lys methylation in the maintenance of Pdx1 activity and 
cell function.
The transcription factor Pdx1 is crucial to islet cell function
and regulates target genes in part through interaction with
coregulatory factors. Set7/9 is a Lys methyltransferase that
interacts with Pdx1. Here we tested the hypothesis that Lys
methylation of Pdx1 by Set7/9 augments Pdx1 transcriptional
activity. Using mass spectrometry and mutational analysis of
purified proteins, we found that Set7/9methylates the N-termi-
nal residues Lys-123 and Lys-131 of Pdx1. Methylation of these
residues occurred only in the context of intact, full-length Pdx1,
suggesting a specific requirement of secondary and/or tertiary
structural elements for catalysis by Set7/9. Immunoprecipita-
tion assays andmass spectrometric analysis using cells verified
Lys methylation of endogenous Pdx1. Cell-based luciferase
reporter assays using wild-type andmutant transgenes revealed
a requirement of Pdx1 residue Lys-131, but not Lys-123, for
transcriptional augmentation by Set7/9. Lys-131 was not
required for high-affinity interactions with DNA in vitro, sug-
gesting that its methylation likely enhances post-DNA binding
events. To define the role of Set7/9 in  cell function, we gener-
atedmutant mice in which the gene encoding Set7/9 was condi-
tionally deleted in  cells (Set). Setmice exhibited glucose
intolerance similar to Pdx1-deficient mice, and their isolated
islets showed impaired glucose-stimulated insulin secretion
with reductions in expression of Pdx1 target genes. Our results
suggest a previously unappreciated role for Set7/9-mediated
methylation in the maintenance of Pdx1 activity and  cell
function.
Deficiency of insulin secretion underlies the transition from
normoglycemia to hyperglycemia in both type 1 and type 2
diabetes (1, 2). Circulating insulin arises almost exclusively
from islet  cells in the pancreas, but our understanding of the
molecular mechanisms governing  cell function in health and
disease remains incomplete. A key protein that is essential for
cell function is the homeobox transcription factor Pdx1.During
mammalian development, Pdx1 is essential for pancreas
organogenesis (3–5). In the adult pancreas, Pdx1 is restricted
primarily to cells and is responsible for the regulation of genes
that are essential to  cell function, proliferation, and survival
(6, 7). In this context, elucidating the molecular mechanisms of
Pdx1 action will be crucial in future attempts to restore  cell
function in the setting of diabetes.
The interaction of Pdx1 with other transcription factors and
cofactors appears to be important in modulating Pdx1 activity
(positively or negatively) at a given target gene. For example, the
formation of a transcriptional complex between Pdx1 and
the basic helix-loop-helix factor NeuroD1 in  cells results in
the formation of a complex with the gene encoding preproin-
sulin (Ins1/2) that permits synergistic activation of transcrip-
tion (8, 9). By contrast, interaction of Pdx1with PCIF1 results in
degradation of Pdx1 protein by the proteasome and a conse-
quent reduction in Pdx1 activity (10). Interactions such as these
suggest a model in which various aspects of Pdx1 activity,
including DNA binding affinity, protein stability, and recruit-
ment of basal transcriptional machinery, are modulated to
achieve homeostatic function of the  cell.
Our laboratory has reported previously that the lysine meth-
yltransferase Set7/9 interacts with Pdx1 to promote transacti-
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vation of an Ins1/2minienhancer (11) that contains the classical
Pdx1 binding sequence (5-TAAT-3) present in elements A3
and A4. Augmentation of transcriptional activity was corre-
latedwith an increase in Lys4methylation of histone 3 (H3) and
the conversion of the initiating isoformofRNApolymerase II to
its elongating isoform. In recent years, several reports have sug-
gested that the methyltransferase activity of Set7/9 is not only
restricted to Lys residues on histones but that it includes Lys
residues of other proteins, such as p53, p65, and estrogen recep-
tor , among others (12–15). These varied methylation events
have been shown to alter the activity or half-life of these pro-
teins, emphasizing that Lys methylation (similar to Ser/Thr
phosphorylation or Lys acetylation) modulates transcription
factor function (16, 17).
In light of these new perspectives on Lys methylation and
Set7/9 action, we asked whether the interactions between
Set7/9 and Pdx1 might affect Pdx1 activity independently of
effects on histones. In this study, our findings reveal a hereto-
fore unappreciated role for Lys-specific methylation of Pdx1 by
Set7/9 in the maintenance of normal  cell function.
MATERIALS ANDMETHODS
Cells, Animals, and Assays—NIH3T3, HEK293, MIN6, and
INS-1 cells were cultured as described previously (11, 18–20).
All animal studies were reviewed and approved by the Indiana
University Institutional Animal Care and Use Committee.
Setd7Loxp/ mice, in which Cre recombinase recognition
sequences (Loxp) flank exon 2, were generated by subcontract
to Ingenious Targeting Laboratories. The neomycin selection
cassette was removed by crossing Setd7Loxp/mice to the FLP1
recombinase expressing mouse strain. Mice were backcrossed
onto the C57BL/6 background for 10 generations. MIP1-
CreERTmice on the C57BL/6 background were provided by Dr.
L. Philipson (21). For induction of Cre-mediated recombina-
tion, mice were gavaged orally with tamoxifen dissolved in pea-
nut oil (mixed for 1 h at 55 °C) at a dose of 5 mg/day/mouse.
Intraperitoneal glucose tolerance tests using 2 g/kg bodyweight
glucose proceeded as described previously (22). Islets were iso-
lated from collagenase-perfused pancreata as described previ-
ously (23). Static glucose-stimulated insulin secretion assays
using islets were performed as described previously (22), and
insulin released into the medium was normalized to total islet
insulin content. Insulin was measured using a mouse insulin
ELISA kit (Alpco Diagnostics).
Recombinant Plasmids, Mutagenesis, and PCR—Plasmids
were generated using standard recombinant techniques. PCR-
generated constructs were verified by automated sequencing.
Recombinant protein was expressed using the Escherichia coli
expression vectors pET21d or pET15b and purified as de-
scribed previously (24). Recombinant Set7/9 protein was pur-
chased fromProspec. Pointmutationswere generated using the
QuikChange site directed mutagenesis kit (Agilent). The fol-
lowing primers were used to make the respective point
mutants: K123R, 5-CAGCTGCCTTTCCCATGGATGAGG-
TCGACCAAAGCTCAC-3 and 5-GTGAGCTTTGGTCGA-
CCTCATCCATGGGAAAGGCAGCTG-3; K126R, 5-TCC-
CATGGATGAAGTCTACCAGAGCTCACGCGT-3 and 5-
ACGCGTGAGCTCTGGTAGACTTCATCCATGGGA-3;
and K131R, 5-CCAAAGCTCACGCGTGGAGAGGCCA-
GTGG-3 and 5-CCACTGGCCTCTCCACGCGTGAGCTT-
TGG-3. CMV promoter-driven vectors (pBAT12) were used
to express wild-type andmutant Pdx1 in HEK293 and NIH3T3
cells as described previously (9). The CMV promoter-driven
vector used to drive Setd7 has been described previously (25).
Methods andprimers for SYBRGreen-based real-timeRT-PCR
have been described previously (26).
Antibodies and Demethylase Inhibitor—Pdx1 antibody was
obtained fromMillipore (catalog no. 07-696). Set7/9 antibodywas
obtained from Cell Signaling Technology (catalog no. 2813).
Monoclonal FLAG M2 antibody was obtained from Sigma-
Aldrich (catalog no. F1804). Anti-Pdx1(Lys-131-methyl) antibody
was generated in rabbits by contract to 21stCenturyBiochemicals
using the following synthetic peptides: methylated peptide 1,
C-Ahx-TKAHAW[K-Me1]GQWAG-amide; methylated peptide
2, Ac-AHAW[K-Me1]GQWAGGA-Ahx-KKC-amide. Gapdh
antibody was obtained from Ambion (catalog no. AM4300).
The fluorophore-labeled secondary antibodies IRDye 700 and
IRDye 800 were obtained from Licor Biosciences. The dem-
ethylase inhibitor BP-107-7 was synthesized using a synthetic
route described previously (27, 28).
Methylation Assays in Vitro—Purified Pdx1 protein (150
nM-1.2M) and Set7/9 protein (200 nM)were incubated at 30 °C
for 3 h in a reaction buffer containing 50mMTris (pH8.5), 4mM
DTT, 5mMMgCl2, 0.05mg/mlBSA, 1M [3H]AdoMet,3 and 50
M AdoMet in 20 l of volume. The reaction was stopped by
the addition of 6 SDS gel loading buffer. Analysis by poly-
acrylamide gel electrophoresis proceeded as described previ-
ously (11).
Coimmunoprecipitation Assays—Immunoprecipitations
fromwhole cell lysates using protein A or protein GDynabeads
(Life Technologies) proceeded as described previously (11).
Immunoprecipitations involving anti-HA antibody, which was
performed using the HA tag immunoprecipitation kit (Pierce).
ChIP assays were performed using the Active Motif ChIP-IT
Express enzymatic kit (catalog no. 53009) according to the pro-
tocol of the manufacturer.
Immunoblot Analysis—Samples were resolved on 10% poly-
acrylamide gels and transferred onto a PVDF membrane (Mil-
lipore). Membranes were exposed to primary antibody over-
night at 4 °C and then processed as described previously (29).
Transient Transfections and Luciferase Reporter Assays—
Cells were transfected usingMetafectene Pro (Biontex) accord-
ing to the instructions of the manufacturer in 6-well tissue cul-
ture plates. After 48 h, whole cell extracts were used to assess
luciferase activity using a commercially available luciferase
assay kit (Promega).
Generation and Purification of the Tandem Affinity Purifica-
tion (TAP) Tag-Pdx1 fromMIN6 Cells—The full-length mouse
Pdx1 cDNA sequencewas inserted in-frame into the pNTAP-C
vector (Stratagene), generating TAP-Pdx1 with the TAP tag
fused to the N terminus of Pdx1. The TAP-Pdx1 sequence was
then subcloned into the pAdTrack-CMV shuttle vector, which
was used to generate recombinant adenoviruses expressing
3 The abbreviation used is: AdoMet, S-adenosylmethionine.
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N-terminal TAP-tagged, full-length Pdx1 as described previ-
ously (30). MIN6 cells were infected with the purified TAP-
Pdx1 or control GFP adenovirus as described previously (30,
31) and lysed 48 h later. TAP Pdx1 was purified using the Inter-
Play TAP purification system (Stratagene) and subjected to
mass spectrometry.
EMSAs—The Ins E-A probe 5-GATCCTTCATCAGGCC-
ATCTGGCCCCTTGTTAATAATCTAATTACCCTAGGT-
CTAA-3was labeled with [32P]ATP using T4 polynucleotide
kinase and duplexed with an unlabeled complementary strand
(5-GATCTTAGACCTAGGGTAATTAGATTATTAACAA-
GGGGCCAGATGGCCTGATGAAG-3). Nuclear extracts
from transfected NIH3T3 cells were isolated as described pre-
viously (19), and around 2 g of total nuclear protein was used
in each EMSA reaction with the labeled Ins E-A probe. Compe-
tition EMSAs were performed using an unlabeled Ins E-A
probe. EMSA reactions proceeded at room temperature for 15
min. The EMSA buffer and electrophoresis protocol have been
described previously (32). The gel was visualized, and competi-
tion EMSAswere quantitated using a PhosphorImager (Molec-
ular Dynamics). Competition EMSAs were modeled on the
basis of single-phase exponential dissociation using the non-
linear least squares fit algorithm in Prism 5.0 software
(GraphPad), and apparent dissociation constants were deter-
mined as described previously (24).
Mass SpectrometryAnalysis—Samples (proteins from in vitro
experiments and fromMIN6 cells) were first denatured with 8
M urea, reduced with 10 mM DTT in 10 mM ammonium bicar-
bonate, alkylated with 55 mM iodoacetamide (prepared in 10
mM ammonium bicarbonate), digested with trypsin, and incu-
bated overnight at 37 °C. The samples in vitro were analyzed
using Thermo Fisher Scientific LTQ Orbitrap Velos Pro and
Surveyor HPLC. Tryptic peptides were injected onto the C18
column. Peptides were eluted with a linear gradient from
3%-40% acetonitrile (in water with 0.1% trifluoracetic acid)
developed over 90min at room temperature, at a flow rate of 60
l/min, and the effluent was electrosprayed into the LTQmass
spectrometer. Blanks were run prior to the sample run to make
sure that there was no significant signal from solvents or the
column. The TSKgel columns (ODS-100 V, 3 m, 1.0  50
mm) were used for the Surveyor HPLC system. The trypsin-
digested Pdx1 immunoprecipitants fromMIN6 cells were pres-
sure-loaded onto a 12-cmmultidimensional protein identifica-
tion technology column as described previously (33). Peptides
were analyzed by MS/MS on an LTQ XL mass spectrometer
following elution during a 10-step multidimensional protein
identification technology run. Protein database searches were
performed using SEQUEST algorithms within Proteome Dis-
coverer (Thermo) against appropriate FASTA sequence data-
bases obtained from UniProt. Database searches included
dynamic modification analysis for mono-, di-, and trimethy-
lated Lys residues and Met residue oxidation.
Statistical Analysis—All data are presented as mean  S.E.
One-way analysis of variance (followed by aDunnett’s post test)
was used for comparisons in which two or more conditions
were compared, and two-tailed Student’s t test was performed
when two conditions were compared. Prism 5.0 software
(GraphPad) was used for all statistical analyses. Statistical sig-
nificance was defined as p 0.05.
RESULTS
Pdx1 Is Methylated by Set7/9 in Vitro at Positions Lys-123
and Lys-131—Recent evidence suggesting that Set7/9 methyl-
ates non-histone proteins led us to investigate first whether the
interaction between Set7/9 and Pdx1 leads to Lys methylation
of Pdx1. We performed methylation reactions in vitro using
purified Pdx1 and Set7/9 proteins and [3H]AdoMet. Incorpo-
ration of the [3H]methyl group into Pdx1 in this reaction is
evidence of protein methylation (11). As shown in Fig. 1A,
[3H]methyl was incorporated into Pdx1 in a concentration-de-
pendentmanner andonly in the presence of Set7/9. By contrast,
no methylation of bovine serum albumin was observed in the
same reaction, suggesting that the methylation is specific for
Pdx1 (Fig. 1A).
Prior studies have suggested that Lys residues in a broad
range of sequence contexts can serve as substrates for Set7/9
(34). Within Pdx1, Lys residues occur in both the N-terminal
transactivation domain (residues Lys-15, Lys-123, Lys-126, and
Lys-131) and the DNA binding homeodomain (residues Lys-
147, Lys-163, Lys-191, Lys-200, Lys-202, Lys-203, Lys-207, and
Lys-208). To narrow the possible Lys residues that may be
methylated by Set7/9, we next performed methylation assays
using different truncated mutants of Pdx1, as shown in Fig. 1B.
Surprisingly, none of the truncated mutants were methylated
by Set7/9 in vitro, suggesting that methylation of Pdx1 requires
the structural context of the full-length protein.
To identify the methylated Lys residue(s) in the full-length
protein, we next performed mass spectrometry of methylated
full-length Pdx1. Broad coverage of the peptides confirmed the
monomethylation of Pdx1 at twoLys residues in theN-terminal
region of the protein (residues Lys-123 and Lys-131) (Fig. 2, A
and B). Data from the mass spectrometric analysis was verified
using mutated Pdx1 proteins in which residues Lys-123, Lys-
126, and Lys-131 in the N-terminal domain were mutated to
Arg (K123R, K126R, and K131R). As shown in Fig. 1C, reduc-
tions in methylation of Pdx1 clearly occurred in the K123R
mutant, but no statistically significant reductionwas seen in the
K131R mutant. Little residual methylation was observed in the
K123R/K131R double mutant. Together, these data suggest
that residue Lys-123 appears to be the kinetically preferred site
formethylation by Set7/9 in vitro, with evidence of lessermeth-
ylation occurring at Lys-131.
Lys-131 of Pdx1 Is Required for Transcriptional Augmenta-
tion by Set7/9—In prior studies, we showed that Set7/9 aug-
ments the transcriptional activity of Pdx1 in the context of a
Pdx1 reporter (containing five tandemPdx1 binding sites). This
result has been ascribed previously to Set7/9-mediated methyl-
ation of H3 (residue Lys-4) at this reporter (11). On the basis of
our results in Fig. 1, we considered the possibility that this tran-
scriptional augmentation by Set7/9might, instead, be a result of
Pdx1 Lys methylation. To test this possibility, we performed
reporter gene activity assays using wild-type andmutated Pdx1
in the mouse-derived cell line NIH3T3, which is devoid of
endogenous Pdx1. As shown in Fig. 3A, when a cDNAencoding
wild-type Pdx1 is cotransfected into NIH3T3 cells with a Pdx1
LysMethylation of Pdx1 by Set7/9
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reporter plasmid containing tandem copies of a Pdx1 binding
sequence (derived from the rat Ins1 E2/A4/A3 promoter ele-
ment) driving luciferase (9), 12-fold activation of luciferase
activity is observed. No activation is observed, however, upon
cotransfection of the reporter with a cDNA encoding Set7/9
alone (Fig. 3A). When cDNAs encoding both wild-type Pdx1
and Set7/9 are cotransfected, a more than additive 18-fold acti-
vation of the reporter is observed. Although mutation of resi-
due Lys-123 to Arg (K123R) had no effect on reporter gene
transactivation, mutation of Lys-131 to Arg (K131R) or the
double mutation K123R/K131R resulted in a loss of transcrip-
tional augmentation by Set7/9 (Fig. 3A). These effects were spe-
cific for the Pdx1 reporter because no significant effects were
observed on the control Gal4 reporter (which contains five tan-
dem copies of the yeast Gal4 upstream activating sequence)
(Fig. 3B). Additionally, the effects of the K131R mutation was
not caused by changes in Pdx1 levels, because all transfected
Pdx1mutants showed similar intensity on immunoblot analysis
(Fig. 3C). These results suggest that, although both Lys-123 and
Lys-131 appear to be targets for methylation by Set7/9 in vitro
(with the former being preferred), only Lys-131 appears to be
required for the transcriptional augmentation of reporter activ-
ity in cells.
Lys methylation has been shown to affect multiple aspects of
transcription factor activity, including protein half-life and
DNA binding affinity (17, 35). We suspected that the effects of
the K131R mutation on Pdx1 half-life were negligible because
proteins levels of the transfected proteins were identical for the
wild type and mutants (Fig. 3C). To test whether loss of tran-
scriptional augmentation activity between Pdx1 K131R and
Set7/9 was due to decreased interaction between the two pro-
teins, a coimmunoprecipitation assay for Set7/9 and Pdx1 using
NIH3T3 cells transfected with wild-type or mutant Pdx1 and
Set7/9 was performed (Fig. 3D). Neither the K131Rmutant nor
the K123R/K131R double mutant exhibited any differences in
interaction with Set7/9, suggesting that the interaction
between Pdx1 and Set7/9 is independent of the target Lys resi-
due being methylated.
To ascertain the effects of the Pdx1mutations onDNAbind-
ing affinity, we next performed EMSAs. Nuclear extracts from
NIH3T3 cells transfected with Pdx1 proteins and Set7/9 were
subjected to EMSA with the 32P-labeled rat Ins1 promoter E-A
element (9, 36). No apparent differences in the intensity of the
Pdx1-specific complex were observed in the EMSAs (Fig. 4A).
To quantitate more precisely whether subtle differences in
binding affinity exist, we performed competition EMSAs using
increasing concentrations of the unlabeled E-A probe. Binding
competition curves were subsequently calculated and modeled
on the basis of single-phase exponential dissociation (Fig. 4B).
As shown in Fig. 4B, none of themutants exhibited dissociation
constants that were different from the wild-type Pdx1 protein.
Taken together, the data in Figs. 3 and 4 suggest that the tran-
scriptional augmentation by Set7/9 that is enabled by methyla-
tion at Lys-131 likely involves transcriptional events that occur
after binding to DNA, such as through the activation of the
RNA polymerase II complex at the promoter (11).
Residue Lys-131 of Pdx1 Is Methylated in Cells—We next
asked whether Pdx1 residue Lys-131 is methylated by Set7/9 in
cells. To assess methylation in cells, we generated a peptide-
based polyclonal antibody against methylated Lys-131 of Pdx1.
FIGURE 1. Pdx1methylation by Set7/9 in vitro. A, a methylation assay in vitro using recombinant Set7/9, [3H]AdoMet and increasing concentrations of Pdx1
proteinwas performed, and then reactionswere subjected to polyacrylamide gel electrophoresis. The first and second panel show fluorography for 3H, and the
third and fourth panels show corresponding Coomassie staining of the same gel. B, methylation assay in vitro using recombinant Set7/9, [3H]AdoMet, and
full-length or truncated Pdx1 proteins was performed, followed by polyacrylamide gel electrophoresis. A schematic of truncatedmutants of Pdx1 is shown in
the right panel, and corresponding 3H fluorography andCoomassie stains are shown in the left panel. Term, terminus;HD, homeodomain.C, methylation assays
in vitrousingWTandmutatedPdx1proteinswereperformedwith correspondingquantitationofmethylatedPdx1protein intensities (normalized to total Pdx1
protein by Coomassie staining). All images shown are representative of at least three experiments. *, p 0.05 compared with wild-type Pdx1.
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Three different peptides (two methylated and one unmethy-
lated at Lys residues) corresponding to the Pdx1 sequence con-
taining Lys-131 were subjected to dot blots using varying dilu-
tions of the antibody. As shown in Fig. 5A, the antibody
exhibited specificity for the Lys-methylated peptides (Fig. 5A).
A corresponding specificity of the antibody formethylated full-
length Pdx1 was observed using recombinant Pdx1 proteins
methylated by Set7/9 in vitro (Fig. 5B). As expected, an almost
complete loss of immunoreactivity was observed with the
K131R mutation. However, some cross-reactivity of the anti-
bodywas observedwithmethylated Lys-123 because theK123R
mutation showed a slight reduction in immunoreactivity (Fig.
5B). These data confirm that Lys-131 is a site formethylation by
Set7/9 in vitro. This antibody was then used to assess themeth-
ylation of Pdx1 proteins immunoprecipitated from cells. Wild-
type and mutant Pdx1 constructs containing an N-terminal
HA) tag were transfected along with Set7/9 into HEK293 cells,
which contain no endogenous Pdx1. Pdx1 proteinswere immu-
noprecipitated using an anti-HA antibody and then subjected
to immunoblotting using the anti-Pdx1(Lys-131-Me) antibody.
As shown in Fig. 5C, second lane, wild-type Pdx1 was methy-
lated in cells, and theK131R andK123R/K131Rdoublemutants
FIGURE 2.MS/MS spectra of Pdx1 in vitro and in MIN6 cells. A, tandem mass spectrum of the peptide GQLPFPWMK showing modification of Lys-123 with
monomethylation (14Da) following treatmentwith recombinant Set7/9 in vitro. The SEQUESTXCorr for this2peptide is 1.83,with appm (parts permillion)
of1.65. (B) Tandem mass spectrum of the3 peptide AHAWKGQWAGGAYAAEPEENKR showing monomethylation (14 Da) of Lys-131 in Pdx1 following
treatmentwith recombinant Set7/9 in vitro. The SEQUEST XCorr for this peptide is 6.19, with a ppmof 0.34. C, representativeMS/MS spectrum from an LTQ ion
trap for the2 peptide AHAWKGQWAGGAYAAEPEENKR showing trimethylation at Lys-131 in Pdx1 in transduced MIN6  cells. The SEQUEST XCorr for this
peptide is 2.24, with a ppm of 19.25.
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showed a clear reduction in methylation. A slight reduction in
the K123R mutant is consistent with cross-reactivity of the
antibody for methylated Lys-123. Taken together, these data
suggest that Lys-131 (and possibly Lys-123) are methylated in
cell lines.
To determine whether Lys-131 is endogenously methylated
in  cells, we immunoprecipitated methylated Lys proteins
from INS-1(832/13) insulinoma cells and then subjected the
immunoprecipitate to immunoblotting using an anti-Pdx1
antibody. Initial experiments from INS-1 cells revealed no
recovery of methylated Pdx1, raising the concern that  cells
may contain demethylases that diminish the ability to detect
Pdx1 methylation. To circumvent this possibility, we pre-
treated INS-1 cells with the Lys demethylase inhibitor
BP-107-7 (Fig. 5D, top panel). INS-1 cells pretreatedwith 10M
BP-107-7 overnight were subjected to immunoprecipitation
using anti-Pdx1 antibody, and the resulting immunoprecipitate
was immunoblotted with anti-methylated Lys antibody. As
shown in Fig. 5D (bottom panel), although INS-1 cells treated
with vehicle showed no recovery of methylated Pdx1, cells
treated with BP-107-7 showed a clear signal for Pdx1. These
data suggest that Pdx1 is endogenously methylated and dem-
ethylated in  cells. To verify methylation at residue Lys-131 in
 cell lines, TAP-tagged Pdx1 was overexpressed in MIN6 
cells using adenoviral gene transfer. The tagged Pdx1 protein
was then purified from MIN6  cells and analyzed by LC/MS/
MS. Pdx1 was found to be both di- or trimethylated at residue
Lys-131 (Fig. 2C shows data for the trimethylated protein). Col-
lectively, these data suggest that Lys-131 is a target of methyla-
tion in cells.
Set7/9 Is Required for the Maintenance of Normal  Cell
Function and Glucose Homeostasis in Vivo—In prior studies,
our group showed that transient knockdown of Set7/9 in islet 
cells results in a reduction in several gene targets of Pdx1 (26),
but the link between Set7/9 and  cell function in vivo has not
been explored. To address this linkmore directly, we generated
mice in which Cre recombinase recognition (Loxp) sites
flanked exon 2 of the gene encoding Set7/9 (Setd7) so that con-
ditional excision of the exon by Cre recombinase would result
in a frameshift and premature termination of the mRNA (Fig.
6A). This strategy ensures the deletion of both the putative
Pdx-1 interaction domain (at the N terminus) and the methyl-
transferase domain (the SET domain) at the C terminus.
Setd7Loxp/ mice were crossed to mice that express the Cre
transgene exclusively in islet  cells when treated with tamox-
ifen (MIP1-CreERT (21). Setd7Loxp/Loxp;MIP1-CreERTmice and
littermate controls (Setd7/;MIP1-CreERT and Setd7Loxp/
Loxp) were treated with five daily doses of tamoxifen at 8 weeks
of age to generate  cell-specific Set7/9 knockout mice (Set	)
and controls, respectively. At 12 weeks of age (3 weeks after
conclusion of tamoxifen treatment), islets isolated from Set	
mice showed a clear reduction in Set7/9 levels by immunoblot
analysis (Fig. 6B).
Set	 mice displayed impaired glucose tolerance following
an intraperitoneal glucose challenge (Fig. 6C). To test the pos-
sibility that impaired glucose tolerance was caused by  cell
FIGURE 3. Transcription augmentation by Set7/9 is dependent upon the Pdx1 residue Lys-131. NIH3T3 cells were transiently cotransfected with Set7/9,
WT andmutant Pdx1 proteins, and either the Pdx1 reporter plasmid or the Gal4 reporter plasmid. Cells were harvested 48 h later, andwhole cell extracts were
used to assay luciferase activity. A, luciferase activities (relative to control transfections without Pdx1) with the Pdx1 reporter plasmid, which contains tandem
elements of the Ins E2/A3/A4 element. A schematic of reporter is shown in the top panel.n
 3 transfections in triplicate; *, p 0.05 for the comparisons shown.
B, luciferase activities (relative to control transfections without Pdx1) with the Gal4 reporter plasmid, which contains tandem elements of the yeast Gal4 DNA
bindingdomain. A schematic of the reporter is shown in the toppanel).n
3 transfections in triplicate.UAS, upstreamactivating sequence.C, immunoblots (for
the indicated proteins) from whole cell extract from transfected cells. Results are representative of three transfections. D, NIH3T3 cells were transfected with
FLAG-Set7/9 and the indicated Pdx1proteins, and thennuclear extractswere subjected to immunoprecipitation (IP) using FLAGantibody and immunoblotted
(IB) using Pdx1 antibody. Results are representative of two experiments.
LysMethylation of Pdx1 by Set7/9
APRIL 10, 2015•VOLUME 290•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 9817
 by guest on N
ovem
ber 23, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
dysfunction, we isolated islets from Set	 mice and controls
and performed glucose stimulated insulin secretion studies in
vitro. As shown in Fig. 6D, islets from Set	 mice displayed
diminished glucose-stimulated insulin secretion compared
with islets from controls, even when corrected for islet insulin
content. These data suggest a defect in insulin secretory mech-
anisms and are reminiscent of defects seen in Pdx1-deficient
islets (37, 38). Gene expression analysis of isolated islets
revealed reductions in the mRNA levels of key Pdx1-regulated
genes, including MafA, Slc2a2, Gck, and Pdx1 itself in Set	
islets compared with controls (Fig. 6E). The pre-mRNA and
mRNAs encoding preproinsulin showed no change and an
2-fold increase, respectively, in Set	 islets compared with
controls, suggesting that the response of this genemay either be
delayed comparedwith the other Pdx1 targets or that it exhibits
a more complex regulation in the absence of Set7/9. Taken
together, the data from Set	mice suggest a role for Set7/9 in
the maintenance of key Pdx1 target genes and overall glucose
homeostasis in vivo andparallel the phenotype seenwith reduc-
tions in Pdx1 itself.
DISCUSSION
Pdx1 is required for both the development and function of
islet  cells, and, as such, the mechanism underlying its regula-
tion of transcription has been the subject of numerous studies.
Nevertheless, the full extent of themechanisms governing Pdx1
action remains to be elucidated. Set7/9 is a Lys methyltrans-
ferase that has been shown to interact with Pdx1 and augment
Pdx1 action at several target genes (26). In this study, we pro-
vide data suggesting that Set7/9-mediated methylation of Pdx1
augments Pdx1 transcriptional activity. Although other studies
have shown that Pdx1 can be regulated by phosphorylation
(39–43), O-GlcNAcylation (44), and sumoylation (45), ours is
the first study to show that Pdx1 can be methylated. Moreover,
we show a close linkage between Pdx1 and Set7/9 in vivo, where
the loss of Set7/9 in  cells closely parallels the phenotype seen
with the reduction in Pdx1 levels.
In recent years, the number of identified non-histone targets
of Set7/9methylation has been increasing. Depending upon the
protein, Lys methylation appears to affect a variety of functions
at the transcriptional level, including protein-protein interac-
tions, protein stability, andDNAbinding affinity (17, 35). Nota-
ble proteins that are substrates of Set7/9 Lys methylation
include p53 (12), estrogen receptor  (14), nuclear factor B
(13, 15, 46), and TATA box binding protein-associated factor
10 (47), among others. In this study, we show evidence that
Pdx1 is methylated at Lys residues in vitro and in  cells. An
important finding in vitro was that recombinant Pdx1 was
methylated by Set7/9 but occurred only in the context of the
full-length protein. This requirement for context-dependent
methylation seemingly differs from those reported in the liter-
ature, where Set7/9 has been shown to methylate Lys residues
of specific small peptides whose sequences could be subse-
quently used to predict the corresponding full-length protein
targets (34, 48). To our knowledge, none of the small peptide
sequences presented in those studies correspond to sequences
in Pdx1. As such, our studies emphasize that targets of Set7/9
and possibly other SET domain-containing methyltransferases
may not be predictable on the basis of peptide sequence speci-
ficity.More detailed structural studieswill be necessary to iden-
tify how specific secondary and tertiary structural folds of Pdx1
allow for its methylation by Set7/9.
Our mass spectrometric and mutational analyses in vitro
demonstrate that Pdx1 is methylated at two Lys residues in the
N-terminal transactivation domain, Lys-123 and Lys-131, with
Lys-123 being the apparent preferential target for Set7/9 in
vitro. Interestingly, Lys-131 seems to be the more relevant tar-
get of methylation when Pdx1 is expressed in cells, and this
suggests that Lys-131 methylation has greater functional con-
sequences in the context of the cellular milieu. Our finding that
Pdx1 methylation becomes more apparent when cells are
treated with Lys demethylase inhibitors also suggests that
methylation may be transient in cells or perhaps regulated
FIGURE 4. Point mutations do not affect DNA binding by Pdx1. A, NIH3T3
cellswere cotransfectedwith theWTormutant Pdx1proteinswith orwithout
cotransfection of Set7/9. Nuclear extracts from transfected cells were har-
vested and subjected to EMSA using the 32P-labeled E-A DNA fragment con-
taining a Pdx1 binding site derived from Ins E2/A3/A4. The positions of the
Pdx1-containing complex and the unbound, free probe are indicated by
arrows. Bottom panel, immunoblots for Pdx1 and GAPDH from the same
nuclear extracts as used for the EMSA. B, quantitation andmodeling of EMSA
reactions (as inA), with increasing concentrations of unlabeled E-Aprobe. For
each Pdx1 mutant, the control condition is the fraction of total probe bound
in the absence of competitor. The ordinate represents probe binding (at the
given competitor concentration) as a percentage of the control condition.
The apparent dissociation constants of the WT and mutant proteins are
shown in the inset, with no statistical differences seen. The data shown are
from three EMSA experiments.
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depending upon the target gene or functions of Pdx1. In this
regard, there are several reports that show that proteins meth-
ylated by Set7/9 are reciprocally regulated by the demethylase
LSD-1 (49–52).
Although methylation of Pdx1 by Set7/9 in vitro resulted in
monomethylation of Lys-131 (and Lys-123), our overexpres-
sion studies in  cells showed that Lys-131 was di- and tri-
methylated. This observation raises an important issue that has
been discussed in the literature on the stoichiometry of Lys
methylation by Set7/9. Some studies have suggested that Set7/9
functions as a dimethyltransferase (53), whereas others suggest
that it is exclusively a monomethyltransferase (54). These
seemingly contradictory observations could be explained by at
least three possibilities. 1)mono- versus dimethylation could be
sequence-dependent. In this respect, studies have shown that
some peptide sequences are dimethylated by Set7/9 in vitro,
whereas other peptide sequences are monomethylated (34). 2)
In cells, interacting proteinsmay alter the nature of Lysmeth-
ylation by Set7/9. For example, the methyltransferase G9a
exhibits differing stoichiometries of methylation in vivo
depending on the presence of interacting proteins (55). 3)
Set7/9 may be the first in a cascade of different methyltrans-
ferases that achieves di- and trimethylation of Pdx1 residue
Lys-131 in cells.
Set7/9 has been shown previously to augment Pdx1 tran-
scriptional activity in reporter gene assays (11). Here we
observed that the Pdx1 residue Lys-131 is necessary for this
augmentation because mutation of this residue to Arg (K131R)
abrogates transcriptional augmentation. Although the tran-
scriptional augmentation by Set7/9 is only about 40%, the
effects of such reductionsmay have biologically significant con-
sequences in the longer term.We next probed possible reasons
for how the K131R mutation abrogates transcriptional aug-
mentation by Set7/9. We found that mutation did not hamper
Pdx1-Set7/9 interactions (as determined by coimmunoprecipi-
tation experiments) or DNA binding affinity (on the basis of
FIGURE 5. Residue Lys-131 of Pdx1 is methylated in cells. A, dot blot analysis using two dilutions of anti-Pdx1(Lys-131-Me) antibodies andmethylated and
unmethylated peptides corresponding to the N terminus of Pdx1 containing residue Lys-131. B, representative immunoblots (top panel) using anti-Pdx1(Lys-
131-Me) antibody or anti-Pdx1 antibody on recombinant Pdx1 proteinsmethylated by Set7/9 in vitro. The quantitation of immunoblots (n
 3) is shown in the
bottompanel. *, p 0.05 comparedwith Pdx1 alone.C, HEK293 cellswere transfectedwith Set7/9 andWTormutantHA-taggedPdx1proteins, and thenwhole
cell extracts were immunoprecipitated using anti-HA antibody, followed by immunoblot analysis using anti-Pdx1 and anti-Pdx1(Lys-131-Me) antibodies (top
panel). The quantitation of methylated Pdx1 (relative to total immunoprecipitated Pdx1, n
 3) is shown in the bottom panel. *, p 0.05 compared with WT
Pdx1. D, top panel, chemical structure of the Lys demethylase inhibitor BP-107-7 (BP). Bottom panel, INS-1 832/13  cells were treated with vehicle or BP-107-7
(10M) overnight, and thennuclear extractswere immunoprecipitated (IP) using anti-methyl Lys antibody followedby immunoblot using anti-Pdx1 antibody.
LysMethylation of Pdx1 by Set7/9
APRIL 10, 2015•VOLUME 290•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 9819
 by guest on N
ovem
ber 23, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
EMSA analysis). However, It remains possible that binding to
target genes in the nucleus may be subtly altered by the muta-
tions. Nevertheless, on the basis of our data, we believe that
Pdx1 methylation at Lys-131 may affect the interactions of
the Pdx1 transcriptional complex with basal transcriptional
machinery. In support of this possibility, we showed previously
that the Pdx1-Set7/9 interaction was associated with activation
of RNA polymerase II (11, 56).
Finally, to interrogate the relationship between Set7/9 and
Pdx1 target genes in  cells in vivo, we generated mice with a
tamoxifen-inducible  cell-specific deletion of Set7/9 (Set	).
Similar to mice with haploinsufficiency of Pdx1, Set	 mice
exhibited glucose intolerance and  cell dysfunction (37). Sev-
eral Pdx1 target genes were reduced in Set	 mice, consistent
with the close functional linkage between Set7/9 and Pdx1. Our
results are similar to those we published previously using RNA
interference to deplete Set7/9 acutely in islets (26). Although
these studies donot definitively prove a link between Set7/9 and
methylated Pdx1 (because the loss of Set7/9 may have conse-
quences on broader gene expression), these results do suggest
that Pdx1 may be dependent upon the action of Set7/9 for full
activity in vivo.
Taken together, our data suggest a previously unappreciated
posttranslational modification of Pdx1 that appears to affect its
transcriptional activity. Our studies show the methylation of
Pdx1 residue Lys-131, the requirement of Lys-131 for the aug-
mentation of gene transcription in reporter assays, the occur-
rence of Lys-131 methylation in  cell lines, and the require-
ment for Set7/9 in the maintenance of at least a subset of Pdx1
target genes in vivo. Some limitations and alternative interpre-
tations of our study must be acknowledged. Most notably, it
remains possible that the effects observed in our reporter assays
or in Set	mice are not directly related to methylation of Pdx1
per se but, rather, to a separate requirement for residue Lys-131
FIGURE 6.  Cell-specific deletion of Set7/9 in mice. A, schematic of WT and mutant alleles present in control and mutant mice, respectively, showing
positions of the exons (numbered) and the Loxp sites. B, Immunoblot analysis of whole cell lysates of islets isolated from Setd7/;MIP1-CreERT (MIP1-Cre),
Setd7Loxp/Loxp (Lox/Lox), and MIP1-CreERT;Setd7Loxp/Loxp (Set	) mice for Set7/9 (top panel) and GAPDH (bottom panel). C, results of intraperitoneal glucose
tolerance test onMIP1-Cre (n
 12), Lox/Lox (n
 9), and Set	 (n
 12)mice (left panel) with a corresponding area under the curve (AUC) analysis (right panel).
*, p 0.05 compared with either MIP1-Cre or Lox/Lox. D, results of glucose-stimulated insulin release assays from islets isolated from MIP1-Cre, Lox/Lox, and
Set	mice (left panel), and the corresponding ratio of insulin secreted at high glucose relative to low glucose is shown in the right panel. n
 3, *, p 0.05
compared with eitherMIP1-Cre or Lox/Lox. E, results of real-time RT-PCR for the indicated genes from islets isolated from control (MIP1-Cre and Lox/Lox) versus
Set	mice. Data are normalized to ActbmRNA levels; n
 4 independent islet isolations; *, p 0.05 compared with control.
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or Set7/9, respectively, on gene transcription. Gene knockin
studies in mice (using the K131R mutation of Pdx1) may be
more appropriate to address this issue in the future. Also, our
studies do not exclude the possibility in vivo that Set7/9 is
directly necessary for the maintenance of chromatin structure
(histone methylation) at several of the Pdx1 target genes exam-
ined or that it acts in concert with  cell transcription factors
other thanPdx1.Nevertheless, our studies provide a framework
to better understand the nuances of transcriptional regulation
by Pdx1. We propose a model in which Pdx1 methylation at
residue Lys-131 via Set7/9 is required for the maintenance of
transcription at selected target genes. Although thismodel does
not exclude the possibility (as purported in prior studies) that
histone methylation by Set7/9 also contributes to transcrip-
tional activity, it emphasizes that transcription factor-cofactor
interactions can achieve functional transcriptional complexes
in many ways.
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